Lawrence Klein - Insider Trading & Ownership

Entity
Individual
Location
C/O Crispr Therapeutics Ag, 610 Main Street 7 Th Floor, Cambridge, MA
Summary
The estimated net worth of Lawrence Klein is at least $2.54M dollars as of September 6, 2024. Lawrence Klein is the President and CEO, Director of Oruka Therapeutics, Inc. and owns shares of Oruka Therapeutics, Inc. (ORKA) stock worth about $2.54M.
All Insider Reports
All Insider Reports

Ownership of Lawrence Klein

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ORKA, ABIO Oruka Therapeutics, Inc. President and CEO, Director $2.54M Aug 29, 2024
CRSP CRISPR Therapeutics AG Cbo & Coo Aug 16, 2022
DYN Dyne Therapeutics, Inc. Director Jul 5, 2022
JSPR, JSPRW Jasper Therapeutics, Inc. Director Jun 7, 2023

Insider Transactions Reported by Lawrence Klein:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.